Lentiviral vectors for cutaneous RNA managing

Area of Science:

• Molecular Biology
• Genetics
• Dermatology

Background:

• Post-transcriptional RNA regulation by small RNAs, like microRNAs (miRNAs), is vital for cellular processes.
• miRNAs play significant roles in skin homeostasis and disease, making them targets for therapeutic interventions.
• The skin's barrier properties present challenges for genetic intervention and studying small RNA functions.

Purpose of the Study:

• To review the use of human immunodeficiency virus (HIV)-derived lentiviral vectors (LVs) for gene transfer into skin.
• To assess the potential of engineered LVs for delivering small RNAs, including miRNAs, for therapeutic applications in skin.
• To highlight the significance of LVs as tools for cutaneous RNA management and in vivo genetic intervention in experimental dermatology.

Main Methods:

• Review of existing literature on lentiviral vector technology for gene transfer.
• Analysis of studies employing LVs for delivery of small RNAs (shRNAs, miRNAs, miRNA inhibitors) in skin models.
• Examination of long-term transgene expression in xenotransplanted skin models using LVs.

Main Results:

• HIV-derived LVs enable efficient gene transfer to skin and establish long-term transgene expression in xenotransplanted skin.
• Engineered LVs are suitable for delivering various small RNA effectors, including miRNAs and miRNA inhibitors.
• LV-mediated delivery of small RNAs shows in vivo applicability for gene expression and regulation in skin.

Conclusions:

• Lentiviral vectors are effective tools for gene transfer and expression in skin, overcoming natural barrier challenges.
• LVs hold significant potential for advancing cutaneous RNA management and in vivo genetic interventions in dermatology.
• Further development of LVs will be crucial for experimental dermatology and therapeutic applications involving small RNAs in skin.